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 Acute control of prostaglandin production is 
essential for normal estrous cyclicity and maintenance 
of early pregnancy.  The rate limiting step for 
prostaglandin production is the activation of 
Phospholipase A2.  There are many phospholipase A2s, 
but few have been investigated in reproductive 
studies.  The objective of this study was to examine 
PLA2 Groups IV and VI protein and mRNA expression in 
the uterine endometrium during the estrous cycle and 
early pregnancy in ewes.  Ewes were monitored for 
estrous and uterine tissues were collected surgically 
on days 5 (n=3), 10(n=3) and 15(n=3) of the estrous 
cycle.  Endometrium from pregnant animals were 
harvested on days 14(n=3), 15(n=1), 16(n=2), 17(n=1) 
or 20(n=2).  Endometrial scrapings were collected in 
attempts to harvest luminal epithelial cells primarily 
and tissue samples were collected to harvest samples 
containing all cellular endometrial components.  
Samples were analyzed by western blot analysis and 
qRT-PCR to detect protein and mRNA expression of both 
PLA2s Group IV and VI.  Western blot results revealed 
 v
that protein expression of Group IVA was greatest on 
day ten of the estrous cycle but was not significantly 
different form days 5 and 15, possibly due to animal 
variation.  Group IVA was significantly elevated on 
day 14 of pregnancy (P<0.05) and remained elevated 
until day 16 when it diminished and a 50kD band 
appeared.  Group VIA analysis showed a cross-reactive 
50kD band that showed no significant change.  qRT-PCR 
analysis for Group IVA of scraping samples revealed 
similar findings showing not only an increase of Group 
IVA mRNA at pregnancy but also during day 10 of the 
estrous cycle (P<0.0001) but little difference was 
seen in tissue samples (P<0.0001).  Group VIA was 
shown to have no mRNA difference in both tissue and 
scraping samples.  These results suggest that PLA2 
expression is not the sole regulator of prostaglandin 
production, but it does play an integral role that is 
tissue and cell type specific in both the estrous 
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INTRODUCTION 
Estrous Cycle and Early Pregnancy of the Ewe 
Maintenance of pregnancy results from complex 
communication between the developing embryo and the 
maternal unit allowing for the maintenance of the 
corpus luteum and resultant progesterone production.  
Particular regulatory signals of interest at this time 
are prostaglandins.  This thesis will attempt to 
provide a basic understanding of the differences in 
prostaglandin production between a cyclic animal and 
one that is in the early stages of pregnancy.  The 
enzymatic cascade that generates prostaglandins will 
also be explored for possible points of local 
regulation. 
 
Luteolysis and the Regulation of Estrous Cyclicity 
 Normal estrous cyclicity in ruminants results 
from the demise of the corpus luteum (CL), the source 
of progesterone (Goff, 2004; Schams and Berisha, 
2004), termed functional luteolysis.  Toward the end 
of the estrous cycle, prostaglandin F2α (PGF2α), the 
luteolytic signal in ruminants, is produced in a 
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pulsatile fashion by the uterine luminal epithelium of 
sheep and cattle (McCracken et al., 1972).  Uterine 
oxytocin receptor concentrations increase toward the 
end of the cycle.  Oxytocin of neurohypophysial and 
luteal origin bind oxytocin receptors (OTR) and 
initiate pulsatile PGF2α secretion, which in turn, 
stimulates release of luteal oxytocin creating a 
positive feedback loop that results in a series of 
pulses of short duration which are effective in 
causing luteolysis.  PGF2α  is delivered to the corpus 
luteum through a counter-current exchange system 
between the utero-ovarian vein and the ovarian artery 
(McCracken et al., 1972).  Early in the estrous cycle 
oxytocin does not stimulate PGF2α  production, but after 
progesterone priming (Pate, 1988), oxytocin stimulates 
PGF2α production under the influence of estrogen during 
an infertile cycle (Barcikowski et al., 1974).   
Uterine production of PGF2α in response to oxytocin 
coincides with the cyclical variation of OTR 
concentration (Roberts et al., 1976). However, 
diminished OTR concentration does not fully explain 
luteal maintenance during early pregnancy.  For 
example, OTR receptor number in pregnant ewes, though 
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decreased, is not limiting (Mann et al., 2001).  Also 
lacking clarity is the regulation of the oxytocin 
receptor.  It has been documented that the up-
regulation of the estrogen receptor is followed by an 
up-regulation of the oxytocin receptor (Spencer et 
al., 1996).  Oxytocin regulation by estradiol may be 
possible by interaction through the AP-1 and Sp-1 
sites on the OTR gene promoter region (Bazer et al., 
2003)since the promoter does not contain an estrogen 
response element (Ivell and Walther, 1999).  But, 
other studies have documented up-regulation of the OTR 
preceding estrogen receptor up-regulation (Wathes and 
Hamon, 1993).  In addition neurohypophyseal release of 
oxytocin is influenced by gonadal steroids (McCracken 
et al., 1996). Cumulatively, these results suggest a 
complex regulation of PGF2α production involving 
estradiol, progesterone, oxytocin, and their 
respective receptors, as well as elements of the 
prostaglandin production pathway such as 
cyclooxygenases, terminal synthases and 
phospholipases, which will later be discussed in 
detail.   
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Deviation from Luteolysis During Early Pregnancy 
 In order to maintain a successful pregnancy, it 
is essential that progesterone levels be maintained.  
For ruminants to accomplish this, the normal cyclic 
progression into luteolysis must be averted (Spencer 
et al., 2004; Spencer et al., 2007).  The developing 
conceptus signals its presence to the maternal unit 
and maintains luteal function.  Upon receiving this 
signal, the maternal unit responds by providing an 
environment for the growth and development of the 
conceptus. 
 Pulsatile PGF2α production is diminished in 
pregnant animals (Peterson et al., 1976) even though 
PGF2α production is elevated above basal levels in some 
species (Zarco et al., 1988).  Oxytocin stimulation of 
PGF2α  production in pregnant animals is diminished when 
compared to corresponding time periods in cyclic 
animals (McCracken, 1980).  OTR concentrations are 
reduced in pregnant animals (McCracken, 1980; 
Sheldrick and Flint, 1985).  The change in OTR 
regulation coincides with the production of a 
substance by the embryo between days 12 and 21 in the 
sheep that was originally referred to as ovine 
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trophoblast protein-1 (Godkin et al., 1982).  More 
recently, this conceptus product was identified as a 
unique interferon (Imakawa et al., 1987) and has been 
designate interferon-τ  (IFNτ )(Roberts et al., 1998).  
In all ruminant species investigated, IFNτ has been 
implicated as the conceptus product responsible for 
the maintenance of early pregnancy.  It has been 
proposed that interferon-τ  breaks down the positive 
feed back loop between oxytocin and uterine PGF2α that 
initiates functional luteolysis (Flint et al., 1992).  
But, as alluded to earlier, OTR concentrations cannot 
completely explain this process (Mann et al., 2001; 
Wathes and Hamon, 1993).  
 Interferon-τ is a protein of 20-24kD produced by 
the extra embryonic trophectoderm of ruminants (Farin 
et al., 1989; Godkin et al., 1984).  The sheep product 
has a mass of 20kD, while the bovine and caprine 
isoforms produce higher mass isoforms due to possible 
N-glycosylation sites (Baumbach et al., 1990).  
Interferon-τ acts by binding high and low affinity 
receptors on the endometrium known as IFNAR1 and 
IFNAR2 (Godkin et al., 1984; Kaluz et al., 1996).  
Interferon-τ binding is thought to initiate an atypical 
 6
JAK-STAT pathway resulting in the release of several 
interferon transcription factors that may directly or 
indirectly suppress uterine estrogen receptors (Bazer 
et al., 1997; Spencer et al., 2007), cytokines, and a 
myriad of enzymes (Hansen et al., 1999; Martal et al., 
1997).  It is speculated that the timing of 
interferon-τ expression is genetically programmed 
through stimulation and inhibition by transcription 
factors associated with blastocyst elongation and 
implantation.  It has been demonstrated that the 
transcription factors c-fos, c-jun and Ets-2 stimulate 
interferon-τ production, in part, by acting at the AP-1 
and Ets-2 sites, respectively, that have been 
identified in the promoter region of the interferon-τ 
gene (Adunyah et al., 1991; Ezashi et al., 1998; 
Imakawa et al., 1993; Yamaguchi H, 1999).  The 
cessation of interferon-τ expression is not completely 
understood but negative regulatory domains have been 
identified on the promoter of the bovine interferon-τ 
gene (Yamaguchi H, 1999).     
 The corpus luteum of pregnancy is more resistant 
to luteolysis than the corpus luteum of the estrous 
cycle.  Studies have shown that pregnant ewes require 
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a higher dose of luteolysins to induce luteolysis when 
compared to cyclic ewes (Inskeep et al., 1975; 
Nancarrow et al., 1982; Silvia and Niswender, 1986).  
One possibility for this action is the increase in PGE2 
production (Silvia et al., 1984), a reduction of ECE1 
and increased catabolism of PGF2α(Costine et al., 
2007).  PGE2 acts in an opposite manner to that of 
PGF2α (Henderson and McNatty, 1975)and may counteract 




Prostaglandins (PG) are key regulators of many 
reproductive processes, including those of estrous 
cyclicity, pregnancy and parturition (Poyser, 1995). 
Concerning ruminant reproduction, the primary focus 
has been on PGF2α and PGE2 because these are produced 
in greatest concentrations by the endometrial 
epithelium during the estrous cycle (Liggins CG et 
al., 1980) and pregnancy (Marcus, 1981).     
A general overview of the prostaglandin 
production pathway, figure 1-1, yields the following 








phospholipase A2 (PLA2) at the sn-2 position in the 
rate-limiting step of PG synthesis resulting in the 
release of arachidonic acid (AA) and a resultant 
lysophospholipid.  AA is then acted upon by a 
cyclooxygenase (COX) in two distinct reactions.  
First, the enzyme performs a cyclooxygenase reaction 
in which two molecules of O2 are added to AA to form 
PGG2.   PGG2 then undergoes a peroxidase reaction where 
it is reduced by two electrons to form PGH2.  The 
resultant bioactive PGH2 can then be converted into 
specific PGs by different PG synthases.  This pathway 
has many points of complex regulation and not all are 
completely understood.  Better understanding of these 
regulatory factors and enzymes may result in the 
development of better control of estrous, increased 
fertility and novel concepts for contraception. 




There are two isoforms of cyclooxygenase, COX-1 
and COX-2, which execute the committed step in the 
biosynthesis of prostaglandins.  The two enzymes have 
similar amino acid sequences (60-65% homology) and 
have similar function and activities, with the 
predominant structural difference in the membrane 
binding domain (Kujubu et al., 1991).   Both 
cyclooxygenases are homodimers (Luong et al., 1996) 
with each monomer having 3 structural domains: 
epidermal growth factor domain, membrane binding 
domain, and the catalytic domain.  The epidermal 
growth factor domain is found at the N terminus and is 
essential for proper folding.  The membrane binding 
domain, found adjacent to the epidermal growth factor 
domain, is formed by hydrophobic and aromatic residues 
that stick out of the helices forming a hydrophobic 
patch that can associate with a hydrophobic side of 
the membrane bi-layer. The globular catalytic domain 
is found at the C terminus and contains a hydrophobic 
channel through the center with the upper half 
containing the cyclooxygenase active site (Picot et 
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al., 1994).  The globular catalytic domain also 
contains many KDEL-like sequences that direct the 
cyclooxygenases to the endoplasmic reticulum and the 
nuclear envelope, with COX-2 being more readily 
associated with the nuclear envelope (Song and Smith, 
1996). 
There is no real difference in the overall 
location of COX1 and COX2 besides the slightly higher 
concentration of COX2 around the nuclear envelope and 
they operate at similar rates. Each monomer has a 
hydrophobic channel that begins at the membrane 
binding domain and allows arachidonic acid, which can 
diffuse freely within cells, and O2 to enter the enzyme 
directly from the lipid bilayer (Luong et al., 1996; 
Picot et al., 1994) from which it has been freed by 
PLA2s.   
Despite the multitude of similarities between the 
isoforms, there are discernable differences that, 
though not completely understood, allow the two 
enzymes to function in different physiological 
capacities.  It has been documented that COX -2 
releases PGH2 more efficiently than COX-1 at 
concentrations of substrate less than 2.5uM 
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(Shitashige et al., 1998; Swinney et al., 1997).    
The active site of COX-2 for the cyclooxygenase 
reaction is about 20% larger than that of COX-1 caused 
in part by a change in the position of helix D at the 
membrane binding domain to produce a larger opening 
allowing more substrate flexibility for the COX-2 
active site (Luong et al., 1996; Picot et al., 1994).  
This increased flexibility may aid in substrate 
recognition and explain some of the subtle kinetic 
differences between the isoforms.  
The isoforms are also known to have varying 
expressions of mRNA and protein during the estrous 
cycle and early pregnancy in many species.  COX-1 is 
expressed constitutively in the endometrial epithelium 
and stromal cells through out the estrous cycle and 
pregnancy in sheep (Charpigny et al., 1997) whereas it 
is not expressed at detectable levels in the bovine in 
either tissue (Arosh et al., 2002).  This constitutive 
expression is not seen with COX-2, which is inducible.  
COX-2 mRNA and protein fluctuate greatly during the 
estrous cycle and pregnancy in both sheep and cattle.  
In cattle, COX-2 mRNA and protein are expressed at a 
higher level starting at day 13 and continuing through 
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the estrous cycle (Arosh et al., 2002).  Similarly in 
ewes, it appears that COX-2 mRNA and protein are 
expressed at basal levels until they are elevated 
around days 10-12 and remain elevated until they 
decrease between days 14 and 16 of the estrous cycle 
(Charpigny et al., 1997; Kim S et al., 2003).   
In pregnant ewes COX-2 mRNA expression increases 
between days 10 and 12, but remains elevated through 
day 16 and declines slowly thereafter (Kim S et al., 
2003).  Despite elevated levels of COX-2 mRNA a 
decrease in COX-2 protein has been document past day 
17 of pregnancy (Charpigny et al., 1997).  In the 
bovine COX-2 protein and mRNA expression remain 
elevated to day 24 of pregnancy (Emond et al., 2004).  
This time of increased expression coincides with the 
production of interferon-τ by the conceptus (Bartol et 
al., 1985; Godkin et al., 1982).  
COX-2 expression is up-regulated in the 
endometrium at the times of luteolysis during the 
estrous cycle, pre-implantation, and implantation 
during early pregnancy. The fluctuating expression of 
the cyclooxygenases at various time points may 
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illustrate multiple roles played by eicosanoids during 
luteolysis and implantation.   
Despite the fact that the cyclooxygenases are the 
committed step of prostaglandin synthesis and are 
differentially expressed in diverse tissues throughout 
the estrous cycle and pregnancy, they do not 
independently determine which PGs are synthesized.  
They appear to simply be necessary machinery for PG 
production but have no bearing on the biosynthetic 
fate of their released bioactive PGH2.  
 
Functional Coupling in Prostaglandin Production 
 The fate of the released PGH2 is decided by the 
final action of the terminal synthase that then acts 
on the PGH2.  There are several reports of terminal 
synthases coupling with both COX-1 and COX-2 (Liou et 
al., 2000; Murakami et al., 2000; Nakashima et al., 
2003; Ueno et al., 2001).  Specifically, Murakami et 
al. have shown prostaglandin E synthase is coupled 
with COX-1 and COX-2 enzymes forming two distinct 
pathways in rats.  Each pathway appeared to be 
differentially regulated according to AA availability 
(Murakami et al., 2000).  Also suggested is that 
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prostaglandin F synthase(PGFS) is coupled with the 
COX-2 in HEK293 cells but this observation still needs 
clarification concerning the many different types of 
PGFS (Nakashima et al., 2003).  As well as terminal 
synthases, COX-1 and 2 have been shown to couple with 
PLA2s (Ueno et al., 2001).  These findings suggest 
compartmentalization of PLA2-COX-Synthase within the 
membrane resulting in production of specific 
prostaglandins.     
 
Prostaglandin Synthases 
 PGH2 is subject to conversion into several 
different prostaglandins through the action of 
specific terminal prostaglandin synthases.  In respect 
to luteolysis and recognition of pregnancy, PGE2 and 
PGF2α are the most readily produced prostaglandins of 
the ruminant uterus and therefore are of the greatest 
interest to the current studies (Liggins et al., 1980; 
Marcus, 1981).   
PGF2α can be produced by several prostaglandin F 
synthases and is known to affect physiological 
processes in many tissue types, including luteolysis 
in ruminants (McCracken et al., 1972).  There are 
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three distinct pathways for PGF2α production. PGD2 11-
keto reductase has been shown to convert PGD2 to PGF2α 
in the presence of NADPH in rabbit liver (Reingold et 
al., 1981; Wong, 1981) and rat lung (Watanabe et al., 
1981). PGE2 can also be transformed to PGF2α by PGE2 9-
keto reductase activity as characterized in the 
chicken heart (Lee et al., 1975) and pre-ovulatory 
follicles of the ewe (Murdoch and Farris, 1988). The 
final common pathway for the formation of PGF2α is 
known to be through the action of PGH2 9,11-
endoperoxide reductase.  This enzymatic activity is 
the primary pathway for PGF2α biosynthesis in the 
bovine lung (Watanabe et al., 1985), and sheep 
vesicular glands (Hamberg and Samuelsson, 1967).  In 
addition, other studies have shown PGH2 to be the 
primary precursor for PGF2α biosynthesis in the bovine 
uterus (Madore et al., 2003).  However, in the bovine 
uterus, PGF2α is thought to be produced by a novel PGFS 
(Madore et al., 2003) as postulated by Urade and 
colleagues (Urade et al., 1995).  Madore et al. showed 
that, despite the ability of endometrial cells to 
produce PGE2 and PGD2, the primary source of PGF2α comes 
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from the reduction of PGH2.  The reduction most likely 
results from the action of the aldoketoreductase 1B5 
enzyme (AKR1B5) localized in the luminal and glandular 
epithelium. An identifying factor of this enzyme is 
the lack of 11-ketoreductase activity that allows most 
other PGF synthases to transform PGD2 into PGF2α 
(Madore et al., 2003).   In addition to PGFS activity, 
AKR1B5 was shown to exhibit 20α-hydroxysteroid 
dehydrogenase activity that is involved in the 
breakdown of progesterone. This secondary activity may 
reduce progesterone’s inhibitory activities that are 
seen through diestrous since AKR1B5 is shown to be up-
regulated by high levels of progesterone (Madore et 
al., 2003).  The up-regulation of AKR1B5 in the uterus 
begins at day 12 of the cycle and remains elevated 
through day 19 approaching luteolysis in cattle 
(Madore et al., 2003).  Interestingly, Arosh et al., 
2004 found that AKR1B5 is down regulated in both the 
CL and the uterus during the maternal recognition of 
pregnancy.  This contradicts reports that PGF2α levels 
are elevated from basal levels in some species (Zarco 
et al., 1988)suggesting a possible alternate method of 
regulation during pregnancy. 
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PGE2, produced by prostaglandin E synthases 
(PGES), has many biological activities depending on 
the cell type and species. PGE synthases have been 
detected in both the microsomal fraction (mPGES) 
(Hamberg and Samuelsson, 1973) and the cytosolic 
fraction (cPGES) (Ogorochi et al., 1987) of cells.  
Microsomal PGES is generally recognized as the 
predominant producer of uterine PGE2 and it is found on 
the perinuclear membrane co-localized with COX-2 
(Murakami et al., 2000).  In the cow uterus overall 
mPGES has been documented to be unvarying during the 
cycle and during the recognition of pregnancy (Arosh 
et al., 2004)despite a documented increase in the 
production of PGE2 versus PGF2α (Asselin et al., 1997).  
Conversely, PGES mRNA and protein levels increase in 
decidual cells and in epithelial cells at the sites of 
implantation in rats (Ni et al., 2002).  Combined, 
this evidence suggests a specific role for increased 
PGE2 production in implantation and decidualization.  
Further support of PGE2 as a promoter of pregnancy is 
seen in the documented increase of mPGES in the CL 
(Arosh et al., 2004)that supports increased PGE2 
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production which may help prevent luteolysis (Pratt et 
al., 1977).   
 
Phospholipase A2s 
 Phospholipase A2s (PLA2) are a broad family of 
acylhydrolases that act on the sn-2 position of 
membrane phospholipids resulting in the release of AA 
and the production of lysophospholipids.  Arachidonic 
acid can act as a second messenger (Hallak et al., 
1994)and is a precursor for eicosanoids and several 
other chemical mediators.  Also, lysophospholipids can 
form an array of important inflammatory mediators in 
many different cell types (Graler and Goetzl, 2002).  
An example is the metabolization into platelet 
activating factor (PAF) (Jackson et al., 1998).  
Despite the ability to perform the previously 
described reaction, assortments of PLA2s have multiple 
enzymatic capabilities.  Due to subtle differences 
between enzymes, PLA2s have been divided into 16 groups 
with many subgroups to organize over 60 different 
enzymes identified as PLA2 isoforms.   These groups 
divide the enzymes according to specific substrate 
specificity and amino acid sequence and are then 
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further split into sub-groups depending on homology 
and splice variants (Six and Dennis, 2000).  This 
would seem to be straight forward, but several enzymes 
were named before the group designation began, 
resulting in several names often describing the same 
enzyme.  For simplicity the enzyme will be referred to 
by the corresponding group and sub-group designation 
in the remainder of the paper. 
 For the purposes of this study, only a few PLA2 
groups were analyzed.  Specifically groups IVA and VIA 
are of interest in the present study.  This does not 
rule out the activity of other PLA2s in reproductive 
physiology, but the aforementioned have been implied 
to have function in prostaglandin synthesis and/or are 
known to localize in the perinuclear area in close 
proximity to the other enzymes involved in 
prostaglandin biosynthesis. 
 As more evidence emerges suggesting functional 
coupling of PLA2-COX-Terminal Synthase, PLA2s are 
likely candidates to explore as regulators of 
prostaglandin production since they catalyze the rate 
limiting step in prostaglandin production.  Also, if 
specific PLA2s act solely in certain prostaglandin 
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pathways, they can be regulated in target tissues with 
minimal impact on other cascades involving AA release.  
Elucidation of such pathways will likely yield new 
therapeutic options.  
 
PLA2 Group IVA  
Group IVA is the best characterized PLA2 of 
interest in our current studies.  Its influence has 
been shown in multiple tissues with several 
physiological functions that all involve the release 
of AA and the production of a resultant 
lysophospholipid.  The pathway for activation is 
controlled by multiple phosphorylation sites that can 
be activated by multiple pathways.  It has been 
suggested, in some cell types, to be activated 
directly through G-protein interaction (Burch et al., 
1986; Jelsema et al., 1987) although more recent 
research still suggests a link with the PLC pathway 
(Graf et al., 1999; Lee J and Silvia, 1994),or p38 
mitogen- activated protein kinase (Waterman et al., 
1996), and extracellular-signal-regulated kinase 




Group IVA, in its inactive state, is found in the 
cytoplasm but has been shown to be translocated to 
perinuclear membranes by vimentin fibrils in response 
to an influx of Ca++ at concentrations consistent with 
those found in physiological responses (Channon and 
Leslie, 1990; Nakatani et al., 2000; Schievella et 
al., 1995).    Translocation, along with 
phosphorylation (Qiu et al., 1993), results in the 
active form of the enzyme that is able to process 
membrane phospholipids.  Several phosphorylation sites 
have been identified, including Ser-437, Ser-454, Ser-
505, and Ser-727 (de Carvalho et al., 1996), but no 
distinct pathway has been divulged for activation (de 
Carvalho et al., 1996; Qiu et al., 1993).  Also 
demonstrated in fibroblast 3T3 cultures, 
phosphorylation of Group IVA must precede the calcium 
influx for full activity (Schalkwijk et al., 1996).  
It is presently unclear if the timing of 
phosphorylation is more imperative for the activity of 
the vimentin head or for PLA2 Group IVA activity.  Once 
phosphorylated, Nakatani et al., 2000 showed 
translocation occurs through the direction of vimentin 
 22
fibrils attached to the C2 domain of PLA2 Group IVA at 
the vimentin head.  Vimentin is believed to assist in 
proper localization of Group IVA with specific 
membrane associated compartments (Nakatani et al., 
2000). 
Group IVA activity in reproductive tissues has 
been studied in many species including the mouse, 
sheep, human, and bovine.  Gene deletion (knock-out) 
studies in mice have associated Group IVA activity 
with some prostaglandin regulated functions of 
reproduction including implantation and parturition 
(Bonventre et al., 1997; Song et al., 2002; Uozumi et 
al., 1997).  These Group IVA deficient mice were 
characterized as having decreased litter size with 
improper implantation and complications with natural 
induction of labor (Bonventre et al., 1997; Song et 
al., 2002; Uozumi et al., 1997).  Although these 
studies clearly illustrate Group IVA’s importance in 
regulation of reproductive processes, they do not 
delineate Group IVA’s physiological roles during 
estrous cyclicity and pregnancy.  Also when compared 
with COX-2 knock-out studies, it becomes evident that 
other PLA2s are active in AA release allowing for 
 23
reproduction, though at reduced efficiency, whereas 
COX-2 deficiency in mice is often fatal and surviving 
females are sterile (Langenbach et al., 1999).   
Few studies have investigated Group IVAs role in 
ruminant reproduction.  Studies in the ewe demonstrate 
that Group IVA expression of mRNA and protein during a 
simulated estrous cycle remain constant during days 
11-14 of the cycle and maintain the ability to respond 
to stimulation (Graf et al., 1999).  These data are 
further supported in vivo by the demonstration that 
samples at multiple time points during the estrous 
cycle maintain constant Group IVA activity (Tamby et 
al., 1993).  These studies were performed on 
endometrial tissue samples that may not contain a high 
enough concentration of luminal endometrial 
epithelium, the origin of most prostaglandin 
production in the uterus(McCracken et al., 1972). 
PLA2 activity may be regulated by oxytocin and 
interferon-τ  since these signals regulate maternal 
recognition of pregnancy and luteolysis.  Oxytocin 
stimulates PGF2α production which is dependent upon 
PLA2 activity; however, oxytocin stimulation of PLA2  
does not induce an increase in Group IVA  mRNA, 
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protein, or activity in the ewe (Burns et al., 2000; 
Graf et al., 1999) suggesting that other PLA2 enzymes 
may be involved in maternal recognition of pregnancy 
and luteolysis in ruminants(Tithof et al., 2007).  
Indirect mechanisms have been suggested in the sheep 
(Graf et al., 1999; Lee J and Silvia, 1994) and cattle 
(Burns et al., 1997). A proposed mechanism involves 
oxytocin induced increases in Ca++ by activation of 
phospholipase C pathway resulting in activation of 
MAPK/PKC activity leading to full activation of Group 
IVA through the Ca++ and phosphorylation activities 
described earlier(Burns et al., 1997; Graf et al., 
1999; Lee and Silvia, 1994).  Unlike oxytocin, 
interferon-τ appears to directly affect Group IVA 
synthesis and activity.  Pregnant sheep exhibited a 
steady decrease in Group IVA activity after day 12 
(Asselin et al., 1997; Burns et al., 1997; Graf et 
al., 1999; Lee and Silvia, 1994).  Similarly, 
interferon-τ  was shown in bovine endometrial 
epithelial cells to decrease Group IVA mRNA and 
protein and subsequently decrease PGF2α production 
after 12 hours even when stimulated by a phorbol ester 
in vitro (Binelli et al., 2000).  Unfortunately, 
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interferon-τ’s mechanism for action in either species 
is not known and could be through cytosolic and/or 
nuclear actions.  Not to be ruled out, as noted by 
Bonney et al. 1987, are possible activities of other 
PLA2s and species differences in luteolysis and 
maternal recognition of pregnancy that have yet to be 
classified. 
 
PLA2 Group VI 
 Group VI PLA2 was first purified in P388D1 
macrophage cells although calcium-independent PLA2 
activity had been previously described in multiple 
species and cell types (Ackermann et al., 1994).  
Unfortunately, little is known about the multiple 
enzymes and isoforms that are classified within Group 
VI.  The gap in knowledge is considerably large with 
regards to Group VI’s roles in reproductive processes. 
Group VIA is a 85-88kDa protein comprised of 8 N-
terminal ankyrin repeats and a conserved lipase motif 
(Tang et al., 1997); but, there are multiple splice 
variants, see figure 1.2, resulting in many active and 
inactive gene products that arise from the same gene 
in humans, rats (Forsell et al., 1999; Larsson et al., 
1998) and most likely some other species. Of these 
splice variants, 40kDa and 50kDa variants have been 
identified (Ackermann and Dennis, 1995; Brant and 
Caruso, 2005; Brant et al., 2006; Manguikian and 
Barbour, 2004).  The separate variants have split 
Group VIA into 5 different splice variants of known 
structure as described by Winstead and colleagues 
(Winstead et al., 2000).  Group VIA-1 is an active 
phospholipase comprised of 752 amino acids containing 
 
Figure 1-2. Schematic of Group VI Isoforms from 
Winstead et al., 2000. 
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eight ankyrin repeats and the conserved GTSTG lipase 
motif.  Group VIA-2, 806 amino acids, is similar to 1 
except, in place of the eighth ankyrin repeat, it 
contains a 54 amino acid insertion derived from exon 9 
of the human gene which is believed to determine its 
localization (Forsell et al., 1999).  Group VIA-3 is 
very similar to VIA-2 but at only 640 amino acids it 
has a shortened C-terminus and it is not yet known if 
this isoform is active.  Also produced are Ankyrin-1 
and Ankyrin-2.  These gene products result in inactive 
enzymes because they lack the lipase motif despite 
containing structure similar to Group VIA-2 and are 
dominant negative inhibitors(Forsell et al., 1999; 
Larsson et al., 1998; Winstead et al., 2000).       
 Although the molecular details of Group VI 
activity are still largely undefined, the structure 
helps to explain some trends that have been identified 
in past experiments.  In early studies, Group VI was 
found to form a tetramer of 270-350kDa that was 
catalytically active (Ackermann et al., 1994; Tang et 
al., 1997).  The formation of an oligomeric structure 
is most likely due to the protein to protein 
interactions common between ankyrin repeats.  It has 
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been documented that ankyrin repeats of group VI are 
necessary in some capacity for standard activity to be 
achieved (Tang et al., 1997).  Structural interaction 
between splice variants is also believed to be a point 
of regulation for group VI.  Ankyrin-1 and 2 are 
believed to bind catalytically competent Group VI PLA2 
enzymes, in turn playing an inhibitory role by 
preventing the formation of catalytically active 
tetramers (Forsell et al., 1999; Manguikian and 
Barbour, 2004; Tang et al., 1997).  In some cases 
ankyrin repeats also coordinate localization to 
phospholipid membranes.  There is mixed evidence for 
such sub cellular localization for Group VI.  There 
are multiple reports describing both the cytosolic 
(Forsell et al., 1999; Saavedra et al., 2006; Tang et 
al., 1997) and membrane (Akiba et al., 1999; Forsell 
et al., 1999; Manguikian and Barbour, 2004) 
localization and activity of these enzymes.  These 
results require more experimentation, and suggest that 
the localization is not only species, but also cell 
type specific.      
 Several other important regulatory aspects of 
Group VI have also been described.  Despite being 
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active in the absence of Ca2+ in vitro, Group VI 
activity has been shown to be intricately regulated by 
calcium stores.  It is known that calmodulin can be 
functionally coupled to Group VI in an inhibitory 
manner (Wolf and Gross, 1996).  But, this inhibition 
can be lifted through localized calcium store 
depletion and the actions of calcium/calmodulin-
dependent protein kinase type II in pancreatic islet β-
cells (Wang et al., 2005).  Also, different kinases 
are involved in the activity of Group VI.  PKCα is 
imperative to the membrane localization and activity 
in P388D1 cells (Akiba et al., 1999; Akiba et al., 
2002)whereas PKCε phosphorylation is implicated in 
Group VIA activity in ventricular myocytes (Steer et 
al., 2002).  A final kinase implicated is p38 MAPK 
which affects Group VI activity in a dose-dependant 
manner in smooth muscle cells (Brant and Caruso, 2005; 
Yellaturu and Rao, 2003).  Many of these activities 
are dependant upon association with ATP (Ackermann et 
al., 1994; Steer et al., 2002; Wolf and Gross, 1996).  
It has since been shown that ATP acts to protect Group 
VI from degradation in oxidation studies (Song et al., 
2006).   
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 Group VI PLA2 has just as many proposed 
physiological roles as points of regulation.  Group VI 
has been demonstrated to be a house keeping enzyme 
involved in phospholipid remodeling in many cell types 
(Baburina and Jackowski, 1999; Barbour et al., 1999; 
Herbert and Walker, 2006; Perez et al., 2004; Saavedra 
et al., 2006).  But this is not true for all cell 
types (Ma et al., 2001; Ramanadham et al., 1999)and is 
not the only function for Group VIA.  Group VIA acts 
in a signaling fashion promoting the production of 
eicosanoids (Akiba et al., 1998; Brant and Caruso, 
2005), lysozyme secretion (Balboa et al., 2003), cell 
division (Herbert and Walker, 2006; Manguikian and 
Barbour, 2004), differentiation (Birbes et al., 
2000)and apoptosis (Balboa et al., 2003; Perez et al., 
2004).  These activities can be stimulated by 
exogenous sources (Akiba et al., 1999; Yellaturu and 
Rao, 2003) or are initiated by the physiological 
intricacies of Group VI splice variant regulation that 
varies between cell types and species.  Such variation 
makes it difficult to extrapolate results from 
previous experiments as universal knowledge.  But, the 
previous descriptions provide insight to some 
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possibilities for activity and regulation within 
reproductive tissues and processes.   
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MATERIALS AND METHODS 
Materials 
 All chemicals were purchased from Fisher 
Scientific, Pittsburgh, PA unless otherwise noted.  
Mature cross-bred ewes were provided by the University 
of Tennessee, Knoxville Experiment Station.  Protease 
Inhibitor Complete EDTA free tablets were purchased 
from Roche Diagnostic Corporation, Indianapolis, IN.  
diethylpyrocarbonate (DEPC) was bought from Sigma-
Aldrich, St. Louis, MO.  Correlate EIA kits were 
purchased from Assay Designs Inc., Ann Arbor, MI.  BCA 
Protein Assay Kit, IgG Anti-rabbit HRP conjugate, 
Super Signal West Femto Maximum Sensitivity Substrate, 
CL-Xposure X-ray film and PVDF membranes were procured 
from Pierce Biotechnology, Rockford, IL.  MagicMark XP 
molecular weight markers were purchased from 
Initrogen, Carlsbad, CA. High Range Pre-stained SDS-
PAGE Standards and iScript Select were bought from 
Bio-Rad, Hercules, CA.  GIVA specific monoclonal 
antibody (SC-454) was obtained from Santa Cruz 
Biotechnology, Santa Cruz.  GIV antibody (MAB166A) was 
procured from Chemicon International Inc., Temecula, 
CA.  IgG Anti-mouse ECL Peroxidase was acquired from 
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GE Healthcare Bio-Sciences Corp., Piscataway, NJ.  
iPLA2 antibody (Group VIA) was obtained from Upstate 
Ltd., Hampshire, United Kingdom.  RNAlater, RLT 
buffer, RNeasy Mini Kit, and RNease-Free DNase set 
were procured from Qiagen Inc., Valencia, CA.  Power 
SYBR was purchased from Applied Biosystems, Foster 
City, CA.  All primers were ordered from Integrated 
DNA Technologies, Coralville, IA.  Clonetech 
Nucleotrap Kit was obtained from Takara Bio Company, 
Otsu, Japan.   
 
In Vivo Collection of Luminal Epithelium 
 Mature cross-bred ewes were monitored for 
standing heat twice daily with vasectomized rams.  
Upon observation of estrus, sheep were scheduled for 
hysterectomy on day 5 (n=3), 10 (n=3), or 15 (n=3) of 
the cycle with estrus being day 0 or bred by intact 
rams and scheduled for hysterectomy on days 14 (n=3), 
15 (n=1), 16 (n=2), 17 (n=1) or 20 (n=2) of pregnancy.  
Day of the cycle was further confirmed by macroscopic 
evaluation of the reproductive tract (Ireland et al., 
1980; Miyamoto et al., 2000).  Pregnancy was verified 
by the presence of an embryo.  Excess blood was 
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removed from the uterus after hysterectomy and it was 
placed immediately on ice.  Horns were separated and 
opened vertically revealing the luminal epithelium.  
Tissue samples were removed containing both epithelium 
and stromal layers from each horn with scissors.  
Remaining Luminal epithelium was scraped from each 
horn with a scalpel.  These samples were weighed and 
placed in 3 volumes (w/v) of Western lysis buffer (154 
mM NaCl, 1 mM KH2PO4, and 5.6 mM Na2HPO4, 1% NP-40,  
0.1% SDS, and 0.5% deoxycholate, pH 7.4 freshly 
supplemented with 1mM DTT, and 2.4% (v/v) protease 
inhibitor solution composed of 4 Complete EDTA Free 
Tablets dissolved in 5mL of water) on ice.  Samples 
were immediately homogenized with a Tissumizer SDT-
1370 (Tekmar, Cincinnati, OH) for thirty seconds on 
ice.  Samples were sonicated with a Sonic Dismembrator 
100 (Fisher Scientific, Pittsburgh, PA) for 3 pulses 
of 10 seconds on ice, aliquoted, and stored at -80oC 
until further use.  
 
In Vivo RNA Collection 
As the luminal epithelium scrape and tissue 
samples were removed from each horn for Western blot 
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analysis samples were also obtained, weighed and 
placed in 1mL of RNAlater overnight at 40C.  The next 
day 1mL of ice cold DEPC treated PBS was added and the 
mixture was centrifuged at 5000 x g for 5 minutes at 
4oC.  The liquid was then drained and tissue was stored 
at -80oC until the RNA could be extracted. 
 
Western Blot 
The total protein concentration was determined 
using BCA Protein Assay Kit (Pierce Biotechnology, 
Rockford, IL) as described by the manufacturers 
protocol. Absorbance was measured at 595nM with a 
Multiscan RC 96-well plate reader (Lab System 
Multiscan RC; Thermo Lab System, Franklin, MA).  10ug 
of total protein from each sample was loaded onto a 
10% (w/v) SDS polyacrylamide gel and electrophoresed 
at 125 V for 1.5 hours. Also added to the gel was one 
lane each of chemiluminescent MagicMark XP molecular 
weight markers (Initrogen, Carlsbad, CA) and High 
Range Pre-stained SDS-PAGE Standards (Bio-Rad, 
Hercules, CA) in order to calculate molecular weight, 
confirm transfer, and monitor migration during 
electrophoresis.  Protein contents were transferred to 
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PVDF membranes (Pierce Biotechnology, Rockford, IL) 
using the Bio-Rad Transblot SD (Bio-Rad, Hercules, CA) 
semi dry transfer system at 1.5 mAmps per cm2 of 
membrane for 30 minutes.  Before transfer, the PVDF 
membrane and a transfer pad were soaked in 60mM tris 
base, 40mM CAPS, and 0.37 M methanol for 30 minutes 
while another transfer pad and the gel was soaked in 
60mM tris base, 40mM CAPS, and 0.1% SDS.  After 
transfer the gels were stained with 0.1% Coomassie 
Blue stain to verify transfer.  The membranes were 
immediately blocked for 1 hour at room temperature by 
shaking in 5% non-fat dry milk (NFDM) in TBST (10 mM 
Tris, 0.05% Tween, and 154mM NaCl).  The blocked 
membrane was placed in 1mL of primary antibody diluted 
with 5% NFDM in TBST to a concentration of 1ug/mL for 
Group IVA specific monoclonal antibody, 2ug/mL for 
Group IV antibody, and incubated overnight at 4oC.  The 
Group VI antibody was diluted to 1:500.  The Group IVA 
and IV antibodies recognize different peptides.  This 
allows for group IVA to only react with Group IVA and 
its various breakdown products where as the Group IV 
antibody can also recognize other Group IV PLA2s such 
as Group IVC. After incubation, membranes were washed 
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4 times in 200mL of TBST for 5 minutes.  1mL 
corresponding secondary antibody diluted by 5% NFDM in 
TBST was applied at a dilution of 1:5000 for IgG Anti-
mouse ECL Peroxidase or 1:1000 for IgG Anti-rabbit HRP 
conjugate (Pierce Biotechnology, Rockford, IL)  and 
incubated for 2 hours at room temperature.  Membranes 
were then washed in 200mL of TBST 3 times for 20 
minutes each.  Super Signal West Femto Maximum 
Sensitivity Substrate was used according to 
manufacturer’s instructions. Protein bands were 
visualized by a 30 second exposure to CL-Xposure X-Ray 
film.  Band intensity was analyzed with the FluoroChem 
5500 (Alpha Innotech, San Leandro, CA) for 
densitometry values.  
Both Group IV antibodies are mouse monoclonal 
antibodies and recognize a sequence in the first 216 
amino acids.  Exactly which sequences are recognized 
is not disclosed by either manufacturer.  The primary 
antibody from santa cruz biochemical claims to be 
specific to Group IVA.  Chemicon’s Group IV antibody 
recognizes Group IVA and other Group IV isoforms.  
Both antibodies will recognize group IVA and may also 
cross react with breakdown products or novel PLA2s yet 
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to be classified.  Similarly the Group VIA antibody 
recognizes a peptide that to date is specific to Group 
VIA.  The antibody will recognize Group VIA and some 
cleavage products but an uncharacterized PLA2 is not 
outside of the realm of possibilities.   
 
RNA Extraction 
 Tissue and scraping samples treated with RNAlater 
were thawed, weighed and homogenized for two 20 second 
bursts with a Tissumizer SDT-1370 in 600 uL of RLT 
buffer per 20mg of sample.  Samples were then 
centrifuged at 10,000 x g for 5 minutes and the 
supernatant collected for RNA extraction.  RNeasy Mini 
Kit spin columns were used for extraction and DNA 
contamination was removed with an on column RNease-
Free DNase Kit treatment.  200uL of supernatant was 
added to each spin column and manufacturer’s 
instructions were followed with the addition of a 5 
minute incubation after the addition of RPE buffer.  
RNA was eluted in 50uL of RNase free water.  RNA 
integrity was evaluated using an Agilent 2100 
Bioanalyzer (Agilent Life Sciences and Chemical 
Analysis, Foster City, CA).  Final RNA concentration 
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was determined using a ND-1000 Spectrophotometer 
(Nanodrop Technologies, Wilmington, DE) and samples 
were stored at -80oC.   
 
Reverse Transcription 
Reverse transcription of RNA samples was 
performed using iScript Select following the 
manufacturer’s instructions using the supplied oligo 
d(T) primer.  500ng and 175ng of total RNA were added 
to each reaction for scrape and tissue samples, 
respectively.  After reverse transcription the cDNA 
samples were stored at -20oC until use in real time 
PCR.   
 
Semi-quantitative Realtime PCR (qRT-PCR) 
 cDNA was diluted with DEPC water to 1:5, 1:25, 
and 1:125 for each sample.  2uL of each dilution was 
plated in duplicate wells along with forward and 
reverse primers (500nM) and 12.5uL of Power SYBR and 
DEPC water resulting in a 25uL reaction volume.  Also, 
a control sample of the previous dilutions was plated 
for quantitative analysis (sheep 121).  Analysis was 
performed under universal conditions with an ABI 7000 
 40
Sequence Detection System (Applied Biosystems, Foster 
City, CA).  Ribosomal protein L19 was used as a 
reference gene with primer sequences of 
ACCCCAATGAGACCAATGAAAT (F) and CAGCCCATCTTTGATCAGCTT 
(R) (Chen et al., 2006).  Phospholipase Group IVA was 
analyzed using the following primer sequences 
GGAAACCATAAAGGAGAACATGAAGAA (F) and 
GCACATCACGTGTAGAATGCAA (R).  These were designed using 
Primer Express software (Applied Biosystems, Foster 
City, CA) to choose primer pairs that span across 
exons of the bovine sequence (NM_001075864) described 
by ensemble.  Partial sheep sequences, produced by our 
lab, were examined with Primer Express software for 
phospholipase Group VIA primer generation. Comparison 
with the bovine sequence for GVIA variant-2 
(XM_615452.3) was used to determine possible splice 
sites. Phospholipase Group VIA was evaluated using as 
CGCACGTGGGACTGCAT (F) and GGTGGCAACTGGGAACAATACT (R) 
as primer sequences.   Clontech Nucleotrap Kit (Takara 
Bio Company, Otsu, Japan) was used to purify PCR 
products for subsequent sequencing at University of 
Tennessee, Knoxville Molecular Biology Resources 
Facility in order to validate primer specificity.  A 
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melting curve was also generated following PCR 
analysis in order to detect any primer dimmers or 
false products in the reactions.         
 
Statistical Analysis 
 All statistical analysis was performed using SAS 
9.1 software (SAS Institute, Cary, NC).  Densitometry 
values obtained from Western blot data were analyzed 
with the following model, y = μ + treatment + 
sheep(treatment) + ε, with each antibody being analyzed 
separately.  Pairwise contrasts were performed between 
each treatment to determine differences.  Analysis of 
qRT-PCR data for primer efficiency was performed, as 
described by Yuan et al., using a simple linear 
regression, Ct= βo+ βconXlcon+ε, to determine data quality 
and primer efficiency (Yuan et al., 2006).  PROC GLM 
was used to construct a multiple regression model, 
Ct=βo+βconXicon+βgeneXigene+βtreatXitreat+βcontreatXiconXitreat+βcongene
XiconXigene+βgenetreatXigeneXitreat+βcongenetreatXiconXitreatXigene+ε also 
described by Yuan et al., in order to estimate ΔΔCt 
number which was the ΔCt for RPL19 minus ΔCt for the 
target gene between our target and control samples 
 42
(Yuan et al., 2006).  A general linear model, y = μ + 
treatment + sheep(treatment) + ε, was used to analyze 
differences of the means between the ΔΔCt numbers of 
each treatment.   qRT-PCR data are presented as fold 
change (2-ΔΔCt)and significance for all experiments was 
determined as P < 0.05. 
RESULTS 
Western blot analysis during the estrous cycle 
 Western blot analysis of proteins prepared from 
luminal endometrial epithelial scrapings collected 
from animals over the estrous cycle revealed (Figure 
3-1) a protein that migrated to a position coinciding 
with 108kD.  This protein was visualized with both 
group IV and Group IVA specific antibodies leading to 
the conclusion that this protein is PLA2 Group IVA.  
Statistical analysis of densitometry values (Figure 3-
2) revealed that the greatest Group IVA expression 
during the estrous cycle occurred at day 10 of the 
cycle before becoming diminished again at day 15.  
However, days 5, 10, and 15 were not seen to be 
statistically different.  Also seen were 45 and 50kD 
bands that do not correspond to any previously 
reported group IV or IVA cross reactive proteins.  
 
 2 3 4 5 61 
 
108kD 
Figure 3-1. Representative expression of PLA2 Group IVA 
during the estrous cycle. Lanes 1&2 Day 5 (n=3).  
Lanes 3&4 Day 10 (n=3).  Lanes 5&6 Day 15 (n=3). 
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Figure 3-2. Estimated densitometry values for PLA2 
Group IVA blot (Day 5=6831.33, Day 10=9289.67, and Day 
15=7041.33). 
 
Western blot analysis of pregnant ewes 
Western blot analysis of proteins prepared from 
luminal endometrial epithelial scrapings of pregnant 
sheep between days 14 and 20 of pregnancy also revealed 
(Figure 3-3) a protein that migrated to a position of 
108kD.  This protein was identified as Group IVA by using 
both a group IV non-specific and a Group IVA specific 
antibody as described previously.  Protein expression, as 
determined by densitometry (Figure 3-5), was shown to be 
highest at days 14 and 15 of pregnancy.  Pair wise 
comparison revealed that Group IVA expression decreased 
following day 15 of pregnancy (P<0.04).   
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Also of interest is the appearance of cross 
reactive proteins against both the Group IV and Group 
IVA antibodies between days 15 and 17 (Figure 3-4) of 
pregnancy that migrates to positions of 68kD and 38kD.  
No Group IV cross reactive proteins have been 
documented at this position.  The 68kD protein 
exhibits greatest expression on day 16 of pregnancy 
where as the 32kD protein remains relatively 
consistent from day 14 to 17.  There are also 45kD and 
50kD proteins that are cross reactive with the group 
IV and Group IVA antibodies that reveal no defined 
pattern and at this time can only be considered as 









Figure 3-3. Expression of PLA2 Group IVA during 
pregnancy.  Lanes 1&2: Day 14 of pregnancy.  Lane 3: 
Day 15 of pregnancy.  Lane 4&5: Day 16 of pregnancy.  
Lane 6: Day 17 of pregnancy. Lanes 7&8: Day 20 of 
pregnancy 











Figure 3-4. Expression of PLA2 Group IV during 
pregnancy.  Lanes 1&2: Day 14 of pregnancy.  Lane 3: 
Day 15 of pregnancy.  Lane 4&5: Day 16 of pregnancy.  












     
Figure 3-5. Estimated densitometry values for PLA2 
Group IV blot (Day 14P=9589.5, Day 15P=7065.00, Day 
16P=3987.5, Day 17P=2917, and Day 20P=1906.5).
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Western blot analysis of pregnancy versus non-
pregnancy 
 Western blot analysis of pregnant and non-pregnant 
samples with both Group IV and Group IVA antibodies 
reveals similar results as seen in the pregnancy and 
estrous cycle blots described earlier.  But, from this 
blot it is determined that group IVA (Figure 3-6) is 
expressed at its highest level on days 14 and 15 of 
pregnancy before decreasing as described previously.  Day 
14 of pregnancy was shown to be significantly higher than 
day 15 of the estrous cycle (P<0. 05). This blot once 
again demonstrated not only the band corresponding to 
Group IVA, but also the unidentified 68, 32, 50 and 45kD 








Figure 3-6. Expression of PLA2 Group IV. Lanes 1&2: Day 
5.  Lanes 3&4: Day 10. Lanes 5&6: Day 15.  Lanes 7&8: 
Day 14 of pregnancy.  Lane 9: Day 15 of pregnancy.  Lane 
10&11: Day 16 of pregnancy.  Lane 12: Day 17 of 









qRT-PCR Analysis of endometrial epithelium 
 All samples were analyzed by qRT-PCR in order to 
demonstrate the fluctuations of phospholipase A2 mRNA 
during the estrous cycle and early pregnancy.  
Analysis of Group IVA expression by luminal 
endometrial epithelial scrapings (Figure 3-7) revealed 
greatly elevated expression (P<0.0001) at day 10 of 
the estrous cycle (11.59), followed by day 14 of 
pregnancy (2.197).  That level was reduced during days 
5 and 15 of the estrous cycle (0.744,0.613) and  days 


















(n=3) (n=3) (n=1) (n=2) (n=1) (n=2) (n=3) (n=3) 
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Figure 3-7. Analysis of qRT-PCR results for Group IVA 
scrape mRNA expression reported as 2-ΔΔCt.  Error bars 
represent the 95% confidence intervals with letter 
grouping representing significance. 
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was greatly decreased after day 16 of pregnancy with 
the lowest expression occurring at day 17 of pregnancy 
(0.051). 
 Group IVA mRNA expression in tissue samples 
(Figure 3-8) did not show differences between most 
treatments (P<0.001).  Similar to the results seen 
from endometrial scrapings, the tissue samples showed 
days 5 and 15 of the estrous cycle (0.273,0.339) once 
again had decreased expression with day 10 exhibiting 
a significant increase.  Unlike the scraping samples, 
all pregnant samples expressed Group IVA mRNA at 
increased levels that were comparable to expression on 
day 10 of the estrous cycle with day 14 of pregnancy 
(1.917) exhibiting the highest expression.   
 Group VIA expression in scraping samples (Figure 
3-9) revealed elevated mRNA expression at days 5 and 
10 of the estrous cycle (0.487,0.792) and decreased 
expression on day 15 of the estrous cycle(P<0.0002).  
The highest mRNA expression levels were observed on 
day 10 and the lowest were observed on day 15 of the 
estrous cycle (0.115).  Expression from all pregnant 
time points for Group VIA was diminished and did not 
significantly differ from one another.   
Tissue samples (Figure 3-10) showed virtually no 
significant difference in Group VIA expression 
(P<0.0062).  Day 15 of the estrous cycle (0.656) and 
days 14 and 20 of pregnancy (0.673,1.232) were seen to 
be the highest in Group VIA mRNA expression with the 
remaining being slightly decreased.  The day 20 value 
may be an artifact due to decreased replications of 
this treatment.  Day 20 tissue RNA extraction only 










Figure 3-8. Analysis of qRT-PCR results for Group IVA 
tissue mRNA expression reported as 2-ΔΔCt.  Error bars 
represent the 95% confidence intervals with letter 
grouping representing significance. 
























(n=3) (n=3) (n=3) (n=3) (n=1) (n=2) (n=1) (n=2)  
Figure 3-9. Analysis of qRT-PCR results for Group VIA 
scrape mRNA expression reported as 2-ΔΔCt.  Error bars 
represent the 95% confidence intervals with letter 
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Figure 3-10. Analysis of qRT-PCR results for Group VIA 
tissue mRNA expression reported as 2-ΔΔCt.  Error bars 
represent the 95% confidence intervals with letter 





Mouse knock-out studies have identified both 
cyclooxygenases and PLA2 Group IVA enzymes to be 
essential to many reproductive processes.  Langenbach 
and colleagues demonstrated that COX-1 knockouts 
developed normally and were relatively healthy.  
Reproduction appeared to be normal in both male and 
female COX-1 deficient mice with normal litter size 
and development. Only the initiation of labor in 
homozygous COX-1 matings appeared to be problematic in 
some animals (Langenbach et al., 1995).   Later 
studies found that labor could be initiated by 
administering PGF2α suggesting a COX-1 specific pathway 
for PGF2α production at the time of parturition 
(Sugimoto et al., 1997).  COX-2 deficient mice 
exhibited marked differences when compared with normal 
mice or COX-1 deficient mice.  COX-2 deficient mice 
showed decreased survivability with only 60% of pups 
surviving to weaning and only 75% of those survived a 
year (Morham et al., 1995).  The surviving females 
were infertile (Morham et al., 1995).  Lim and 
associates took an in depth look at the causes of 
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infertility in COX-2 deficient mice.  The most likely 
cause of infertility was due to failed ovulation and 
severely hampered oocyte development.  Outside of 
unsuccessful ovulation and oocyte maturation, the 
transfer of normal blasocysts into COX-2 deficient 
dams revealed severely restricted implantation and an 
inhibited decidualization reaction (Lim et al., 1997).  
Bonventre and associates demonstrated that PLA2 Group 
IVA knockouts have similarities with both COX-1&2 
knockouts.  Like COX-1, Group IVA deficient mice were 
seen to develop normally with a typical lifespan.  
Unlike COX-1 knockouts, Group IVA deficient mice had 
decreased reproductive efficiency with decreased 
litter size and improper spacing of implantation sites 
(Bonventre et al., 1997; Song et al., 2002).   The 
pups at parturition, though anatomically normal, were 
born dead due to problems with the initiation of labor 
(Bonventre et al., 1997) similar to results seen in 
COX-1 studies.  Such results implicate Group IVA’s 
involvement in reproduction though it is not clear 
what roles it plays in the processes of 
decidualization, implantation, and parturition.  When 
both cyclooxygenase and Group IVA knockout results are 
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compared it is of interest that the COX-2 knockout 
resulted in sterility on many levels where as Group 
IVA knockout significantly reduced fertility but did 
not completely inhibit the reproductive process.  Such 
results implicate that, though efficiency may be 
reduced, alternate PLA2s may be responsible for, or act 
in redundancy with PLA2 GIVA in initiating AA release 
allowing for reproductive processes to continue.     
Group IVA protein expression in endometrium 
samples was demonstrated to be consistent across the 
estrous cycle with similar levels of activity at 
different time points (Graf et al., 1999).  These 
findings are consistent with statistical results from 
western blot analysis (Figures 3-1 and 3-2) which 
showed no difference in protein expression between 
endometrial epithelium samples from day 5, day 10 and 
day 15 of the estrous cycle despite being numerically 
increased at day 10 of the cycle.  Group IVA mRNA 
expression in endometrium samples (Figure 3-8), 
containing stroma, glands, and blood vessels, was seen 
to have only a slight increase at day 10 of the 
estrous cycle of approximately 25% which is similar to 
previously seen results in endometrial samples (Graf 
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et al., 1999).   This is puzzling due to the change in 
prostaglandin production during this time.  
Specifically, PGF2α production increases as the estrous 
cycle progresses.  PLA2, the rate limiting enzyme in 
prostaglandin production, would be expected to alter 
its expression and/or activity.  Conversely, Group IVA 
protein expression in endometrium samples appeared to 
remain relatively constant and shows no response to 
oxytocin stimulation despite the ability of broad 
spectrum PLA2 inhibitors to block PGF2α production (Lee 
and Silvia, 1994).  Such results suggest an 
alternative regulation of the prostaglandin production 
pathway that may act through different tissues, a down 
stream enzyme in the cascade, another PLA2 whose 
activity is yet to be characterized, or regulation of 
enzyme activation.      
Interestingly, a distinct increase, by 16 fold, 
of Group IVA mRNA was seen in luminal epithelial 
scraping samples at day 10 of the cycle (Figure 3-7).  
This level then returned to a level similar to that 
seen on day 5 of the cycle by day 15.  These results 
contradicted those previously seen (Graf et al., 1999) 
in endometrial samples.  This discrepancy between 
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sample types seen both in COX-2 (Charpigny et al., 
1997; Kim et al., 2003)and Group IVA expression 
identifies the key role that the epithelial cell layer 
plays in prostaglandin production and uterine 
regulation.  Western blot analysis of endometrial 
epithelium also showed an increase at day 10 of the 
estrous cycle (Figures 3-1, 3-2, & 3-6).  
Unfortunately the increase is not significant when 
densitometry values were analyzed.   With the 
development of internal controls, such as β-actin, 
allowing for normalization, gel to gel comparison and 
increased number of samples, the increased protein 
expression at day 10 of the cycle may become 
significant due to greater statistical power.  The 
development of internal controls would be necessary 
since there are no pure forms for each of our target 
proteins currently available for standard curve 
generation in order to normalize the data obtained 
from densitometry analysis.  These results are 
supported by the qRT-PCR findings in endometrial 
epithelium (Figure 3-7).  Also, the naked eye detects 
a difference especially when viewing the western blot 
of our most representative samples (Figure 3-6).  
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These results follow more closely the physiological 
production of prostaglandin and reported production of 
prostaglandins specifically by the luminal endometrial 
epithelium (McCracken et al., 1972).  Though the 
insight into Group IVA protein and mRNA expression is 
valuable it does not completely explain the regulation 
of prostaglandin production since there are multiple 
regulatory events controlling maximal activity, such 
as calcium influx and phosphorylation, yet to be 
characterized in this model. 
PLA2 expression during early pregnancy exhibits 
dramatic changes (Figures 3-3, 3-4 & 3-5).  At day 14 
of pregnancy, the time of early interferon-τ production 
by the trophoblast in sheep, group IVA protein was 
seen to be elevated when compared with day 15 of the 
estrous cycle (Figure 3-6). Group IVA mRNA was also 
increased 3 fold in luminal epithelial scrapings at 
this time (Figure 3-7).  Conversely, interferon-τ was 
shown in vitro to suppress group IVA expression and 
decrease PGF2α production in BEND cells stimulated by 
phorbol esters.  Our results support in vivo 
prostaglandin production which increases during early 
pregnancy in sheep (Silvia et al., 1984). In addition, 
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the promoter region of the Group IVA gene contains 
multiple interferon response elements (Wu et al., 
1994) which could result in its up regulation in vivo.  
Tamby and colleagues observed that PLA2 activity 
decreased beginning at day 12 of pregnancy in the ewe 
(Tamby et al., 1993).  Our results do not show a 
significant decrease in Group IVA protein or mRNA 
expression until day 16 of pregnancy in luminal 
epithelial scrapings (Figures 3-3 & 3-7).  The 
discrepancy between the day of decrease in expression 
and activity is due to animal, sample, or methodology 
differences.  Endometrium samples were observed to 
have no variation in Group IVA mRNA expression (Figure 
3-8) between day 15 of the estrous cycle and all days 
of pregnancy tested.  Also, an intact enzyme does not 
denote activity due to the involvement of further 
processing and cofactors resulting in maximal activity 
as discussed earlier.  Interestingly, the decrease in 
Group IVA protein and mRNA expression on day 16 of 
pregnancy in our study coincides with maximal 
interferon-τ production by the embryo (Bartol et al., 
1985; Godkin et al., 1982).  Further study is needed 
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to determine if interferon-τ directly or indirectly 
stimulates these changes. 
 Interestingly, there was an appearance of 68 and 
32kD Group IVA cross reactive proteins during days 15-
17 of pregnancy with maximum expression on day 16 of 
pregnancy (Figures 3-4 & 3-6).  The proteins were 
recognized by both the Group IV and Group IVA specific 
antibodies.  These findings have not been reported in 
in vivo samples before, but similar findings have been 
demonstrated in studies of Group IVA cleavage by 
caspases(Adam-Klages et al., 1998; Luschen et al., 
1998).  Early reports demonstrated that caspase-3, 4, 
and 8 possessed the ability to cleave PLA2 group IVA to 
enzymatically inactive 68/70kD and 32kD fragments 
(Adam-Klages et al., 1998; Luschen et al., 1998).  
Later studies found the 68/70kD fragment had greater 
membrane affinity than the intact enzyme resulting in 
dual competitive inhibition for membrane/substrate 
binding and phosphorylation (Atsumi et al., 2000).  
Caspase activity has been shown to be increased in the 
presence of interferon-α (Boccellino et al., 2004).  
Collectively this may suggest an interferon mediated 
mechanistic shift away from inflammation, similar to 
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that noted during apoptosis, allowing differentiation 
and successful implantation without initiation of an 
inflammatory response.  Another point of interest is 
the timing of possible caspase cleavage of Group IVA.  
This appears to occur at or after day 16 of pregnancy.  
At this time the uterus is preparing for implantation 
and decidualization in sheep (Spencer et al., 2004).  
This is a time of cellular reorganization in which 
caspases have been implied in other tissues to play an 
essential role in the cascade signaling for terminal 
differentiation (Okuyama et al., 2004) resulting in 
the restructuring of cellular membranes and function.   
 A final result of interest is the lack of change 
in Group VIA mRNA with in both endometrium and 
endometrial epithelial samples (Figures 3-9 & 3-10).  
Previous studies had shown a sharp decrease in PGF2α 
production when Group VIA was inhibited by bromoenol 
lactone in endometrial cell cultures under the 
stimulation of oxytocin (Tithof et al., 2007).  Such 
results implicate changes in Group VIA expression 
and/or activity as a key factor in PGF2α production at 
the time of luteolysis.  Our mRNA and western blot 
results did not support such findings in vivo.  
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Western Blots (not pictured) were seen to be 
inconclusive yielding a faint unidentified 50kD band 
that was constitutively expressed.  A similar band was 
recognized as a caspase-3 cleavage product by Lauber 
and associates but it’s activity was never described 
(Lauber et al., 2003). Such results may be due to the 
lack of sheep specific antibodies.  The qRT-PCR 
results displayed minimal expression of Group VIA when 
compared with Group IVA, with little change between 
day of the cycle or early pregnancy in both 
endometrial and endometrial epithelium samples.   
A preliminary result sparking curiosity was that 
a previous preparation of samples abandoned by our lab 
involving multiple high speed centrifugations after 
sonication, yielded a 28kD band that appeared to 
increased during the estrous cycle and become 
diminished in early pregnancy.  Though further 
research is needed for verification, this could be the 
result of Group VIA cleavage by caspase.  Group VIA 
can be cleaved by caspase-3 resulting in a 28kD 
fragment that increases fatty acid release in 
apoptotic cells (Atsumi et al., 2000; Lauber et al., 
2003).  If this were the case, the rapidly changing 
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endometrial cells may undergo a change resulting in an 
increase in localized caspase-3 activity that would 
splice the small amounts of Group VIA into active 28kD 
enzymes resulting in increased activity.  Zhoa and 
colleagues have identified a unique pathway in ovarian 
cancer cells that does not induce apoptosis in which 
Caspase-3 cleaved Group VIA produces lysophosphatidic 
acid which in turn initiates the activation of Group 
IVA causing an increase in AA production (Zhao et al., 
2006).  Increased release of AA by cleaved Group VIA 
and activated Group IVA may result in elevated 
prostaglandin production that is seen in response to 
oxytocin.  Further investigation of protein expression 
and activity is needed using PLA2 activity assays and 
western blot analysis to verify this theory.              
 These findings further implicate the role of PLA2s 
in complex regulations that maintain proper uterine 
function during the estrous cycle and early pregnancy.  
Though PLA2’s expression is not the sole regulator of 
prostaglandin production, PLA2s do play an integral 
role that is tissue and cell type specific.  Their 
roles appear to be intertwined with the processes of 
the estrous cycle and early pregnancy both as 
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substrates and enzymes within multiple cascades that 
allow for their activity in divergent processes.  
Future studies should explore the expression of other 
PLA2s, such as secretory PLA2s, in these tissues as 
well as the activity of all studied isoforms to 
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